{"nct_id":"NCT04655976","title":"Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2020-12-08","start_date_type":"ACTUAL","primary_completion_date":"2025-06-05","primary_completion_date_type":"ACTUAL","completion_date":"2027-03-30","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GSK"]}